G.CLIPS BIOTECH
keyboard_backspaceBack to Home
Contact
41 RUE DE LA DECOUVERTE
31670 LABEGE
France
CEO
About us
G.CLIPS changes paradigm of therapeutics targeting membrane proteins. We have designed the first platform of generation, profiling and optimization of lead-like therapeutics targeting membrane proteins in their pathology-like environment.
G.Screen Platform is an enabling technology for Translational Research at discovery level based on our expertise in Lipidomic & Protein Membrane Science used in our proprietary mixes and assays.
G.screen is thus an Integrated Conformational Target Platform for New Class of mAbs and for Immune Cell Therapies.
Business offer
G.CLIPS offers Membrane proteins purified and stabilized in the desired conformation and specific environment for immunization, antibody screenings, in vitro assay development and pharmacological characterization. We also offer functional testing, pharmacological profiling and target validation based on proprietary assays and using our purified and stabilized membrane proteins.
Activities
- Service
- Oncology
- Nervous Central System
- Immunology
- Inflammation
- Target selection & validation
- Gene / protein discovery
- Expression and pathway analysis of target
- quantification of target
- Assay development in in-vitro & in-vivo models
- Research exploratory companion biomarkers
- Hit discovery
- Screening & Identification
- Immunotherapy lead generation
- Biophysical profile
- Binding & Affinity
- Potency & Specificity
- Functional effects
- Pharmacology & Biological activity
- Mode of Action
- Cell activation
- Ex-vivo activation (cell transfer)
- Target Identification
- Gene / protein discovery
- Expression and pathway analysis of target
- quantification of target
- Assay development in in-vitro & in-vivo models
- Adoptive T Cell Major Challenges in Solid Tumors
- Tumor associated Antigen
- Microenvironment
- Accessibility of tumor cells
